Is GT Biopharma Inc (GTBP) undervalued? · $17.4M cap
GT Biopharma Inc (GTBP) is a biotechnology company listed on NASDAQ.
This page asks whether GT Biopharma Inc (GTBP) looks cheap on cached numbers — not a DCF toy and not a buy alert.
Without a cached income statement, “undervalued GTBP” is a slogan. Wait for the print.
GTBP currently screens at market cap $17.4M. Cheap versus history or peers still needs a filing reason; a low multiple can be a value trap.
A new GTBP 10-Q can flip this screen overnight. The SEC page is the source.
Not investment advice. Compare GTBP to the stock page model before you treat a low multiple as a gift.
Not investment advice.